JP6420969B2 - ポリメトキシフラボノイド溶解組成物及びその製造方法 - Google Patents
ポリメトキシフラボノイド溶解組成物及びその製造方法 Download PDFInfo
- Publication number
- JP6420969B2 JP6420969B2 JP2014106587A JP2014106587A JP6420969B2 JP 6420969 B2 JP6420969 B2 JP 6420969B2 JP 2014106587 A JP2014106587 A JP 2014106587A JP 2014106587 A JP2014106587 A JP 2014106587A JP 6420969 B2 JP6420969 B2 JP 6420969B2
- Authority
- JP
- Japan
- Prior art keywords
- polymethoxyflavonoid
- nobiletin
- composition
- tangeretin
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 62
- 238000004519 manufacturing process Methods 0.000 title claims description 17
- ULSUXBXHSYSGDT-UHFFFAOYSA-N tangeretin Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 ULSUXBXHSYSGDT-UHFFFAOYSA-N 0.000 claims description 72
- OBIOZWXPDBWYHB-UHFFFAOYSA-N Nobiletin Natural products C1=CC(OC)=CC=C1C1=C(OC)C(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 OBIOZWXPDBWYHB-UHFFFAOYSA-N 0.000 claims description 49
- MRIAQLRQZPPODS-UHFFFAOYSA-N nobiletin Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 MRIAQLRQZPPODS-UHFFFAOYSA-N 0.000 claims description 49
- IECRXMSGDFIOEY-UHFFFAOYSA-N Tangeretin Natural products COC=1C(OC)=C(OC)C(OC)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C=C1 IECRXMSGDFIOEY-UHFFFAOYSA-N 0.000 claims description 36
- 239000000463 material Substances 0.000 claims description 29
- 239000002904 solvent Substances 0.000 claims description 28
- -1 polyoxyethylene Polymers 0.000 claims description 22
- 239000004359 castor oil Substances 0.000 claims description 17
- 235000019438 castor oil Nutrition 0.000 claims description 17
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 17
- SWQUTKGVXGTROS-UHFFFAOYSA-N bis(2-ethoxyethyl) butanedioate Chemical compound CCOCCOC(=O)CCC(=O)OCCOCC SWQUTKGVXGTROS-UHFFFAOYSA-N 0.000 claims description 14
- 229940119676 diethoxyethyl succinate Drugs 0.000 claims description 14
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 13
- 229930195729 fatty acid Natural products 0.000 claims description 13
- 239000000194 fatty acid Substances 0.000 claims description 13
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 12
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 11
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 10
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 8
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 8
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 8
- 229940068977 polysorbate 20 Drugs 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 4
- 235000011187 glycerol Nutrition 0.000 claims 2
- 239000002537 cosmetic Substances 0.000 description 14
- 235000020971 citrus fruits Nutrition 0.000 description 13
- 239000003814 drug Substances 0.000 description 13
- 241001672694 Citrus reticulata Species 0.000 description 11
- 229940079593 drug Drugs 0.000 description 8
- 229920000858 Cyclodextrin Polymers 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 229930014626 natural product Natural products 0.000 description 6
- 230000000144 pharmacologic effect Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 5
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 5
- 241000207199 Citrus Species 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 241000548268 Citrus deliciosa Species 0.000 description 3
- 240000002319 Citrus sinensis Species 0.000 description 3
- 235000005976 Citrus sinensis Nutrition 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000675268 Citrus leiocarpa Species 0.000 description 2
- 244000276331 Citrus maxima Species 0.000 description 2
- 235000001759 Citrus maxima Nutrition 0.000 description 2
- 240000000560 Citrus x paradisi Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000001116 FEMA 4028 Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 2
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 2
- 229960004853 betadex Drugs 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000003381 solubilizing effect Effects 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 244000183685 Citrus aurantium Species 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 241001673112 Citrus clementina Species 0.000 description 1
- 241000054078 Citrus depressa Species 0.000 description 1
- 241000951471 Citrus junos Species 0.000 description 1
- 241001573186 Citrus keraji Species 0.000 description 1
- 241000679029 Citrus kinokuni Species 0.000 description 1
- 240000004307 Citrus medica Species 0.000 description 1
- 241000190409 Citrus nobilis Species 0.000 description 1
- 241001573187 Citrus oto Species 0.000 description 1
- 241001573195 Citrus suhuiensis Species 0.000 description 1
- 241000675110 Citrus sunki Species 0.000 description 1
- 241000555678 Citrus unshiu Species 0.000 description 1
- 241001507939 Cormus domestica Species 0.000 description 1
- 241000510678 Falcaria vulgaris Species 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 241000450082 Joppa Species 0.000 description 1
- 244000179970 Monarda didyma Species 0.000 description 1
- 235000010672 Monarda didyma Nutrition 0.000 description 1
- WXOMTJVVIMOXJL-BOBFKVMVSA-A O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@H](O[C@]2(COS(=O)(=O)O[Al](O)O)O[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]2OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O Chemical compound O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@H](O[C@]2(COS(=O)(=O)O[Al](O)O)O[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]2OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O WXOMTJVVIMOXJL-BOBFKVMVSA-A 0.000 description 1
- 229940123973 Oxygen scavenger Drugs 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241001478745 Prosartes lanuginosa Species 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 235000020054 awamori Nutrition 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 229960001777 castor oil Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008278 cosmetic cream Substances 0.000 description 1
- 239000008271 cosmetic emulsion Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000000774 hypoallergenic effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229940016593 peg-20 glyceryl isostearate Drugs 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
本発明の組成物は、ポリメトキシフラボノイド又はポリメトキシフラボノイド含有物と可溶化剤とを含むポリメトキシフラボノイド溶解組成物に関する。
Claims (4)
- ノビレチン及びタンゲレチンからなる群から選ばれる少なくとも1種のポリメトキシフラボノイド又は該ポリメトキシフラボノイド含有物と
コハク酸ジエトキシエチル、ジプロピレングリコール、ポリオキシエチレン硬化ヒマシ油及びポリオキシエチレンソルビタン脂肪酸エステル類からなる群から選ばれる少なくとも1種の可溶化剤とを含み、
グリセリンを含まず、かつ、
該ポリメトキシフラボノイドの濃度が2w/v%以上である、
ポリメトキシフラボノイド溶解組成物。 - 前記ポリオキシエチレン硬化ヒマシ油がPEG−20水添ヒマシ油である、請求項1に記載のポリメトキシフラボノイド溶解組成物。
- 前記ポリオキシエチレンソルビタン脂肪酸エステル類がポリソルベート20である、請求項1又は2に記載のポリメトキシフラボノイド溶解組成物。
- グリセリンを添加せずに、
ノビレチン及びタンゲレチンからなる群から選ばれる少なくとも1種のポリメトキシフラボノイド又は該ポリメトキシフラボノイド含有物と
コハク酸ジエトキシエチル、ジプロピレングリコール、ポリオキシエチレン硬化ヒマシ油及びポリオキシエチレンソルビタン脂肪酸エステル類からなる群から選ばれる少なくとも1種の可溶化剤と
を混合することにより、該ポリメトキシフラボノイドの濃度が2w/v%以上であるポリメトキシフラボノイド溶解組成物を得る工程を含む、ポリメトキシフラボノイド溶解組成物の製造方法。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014106587A JP6420969B2 (ja) | 2014-05-22 | 2014-05-22 | ポリメトキシフラボノイド溶解組成物及びその製造方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014106587A JP6420969B2 (ja) | 2014-05-22 | 2014-05-22 | ポリメトキシフラボノイド溶解組成物及びその製造方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2015221761A JP2015221761A (ja) | 2015-12-10 |
JP6420969B2 true JP6420969B2 (ja) | 2018-11-07 |
Family
ID=54785015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014106587A Active JP6420969B2 (ja) | 2014-05-22 | 2014-05-22 | ポリメトキシフラボノイド溶解組成物及びその製造方法 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6420969B2 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102417319B1 (ko) * | 2017-09-28 | 2022-07-06 | (주)아모레퍼시픽 | 용해도가 향상된 아피게닌을 포함하는 탈모 완화 조성물 |
WO2020122100A1 (ja) * | 2018-12-12 | 2020-06-18 | 森永乳業株式会社 | ポリメトキシフラボノイドの溶解性向上方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2615345B2 (ja) * | 1992-12-28 | 1997-05-28 | 三栄源エフ・エフ・アイ株式会社 | 呈味改善剤及び呈味改善方法 |
JP4992164B2 (ja) * | 2000-04-19 | 2012-08-08 | 日油株式会社 | 化粧料組成物 |
JP4117119B2 (ja) * | 2000-07-05 | 2008-07-16 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 脂溶性物質の可溶化液剤 |
JP2002020220A (ja) * | 2000-07-06 | 2002-01-23 | Nippon Surfactant Kogyo Kk | 可溶化剤組成物 |
JP2005213178A (ja) * | 2004-01-29 | 2005-08-11 | Maruzen Pharmaceut Co Ltd | TNF−α産生抑制剤、エストロゲン様作用剤及び皮膚外用剤 |
WO2012105546A1 (ja) * | 2011-01-31 | 2012-08-09 | 株式会社シクロケムバイオ | 脂溶性物質を含む水溶液の製造方法 |
-
2014
- 2014-05-22 JP JP2014106587A patent/JP6420969B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JP2015221761A (ja) | 2015-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6420969B2 (ja) | ポリメトキシフラボノイド溶解組成物及びその製造方法 | |
Buarque et al. | Choline chloride-based deep eutectic solvent as an inhibitor of metalloproteases (collagenase and elastase) in cosmetic formulation | |
JP2008063266A (ja) | 抗老化剤、美白剤、抗酸化剤、および抗炎症剤 | |
JP2023542975A (ja) | 少なくとも一つのヒドロキシチロソール及び、少なくとも一つのスルフォラファンを含む相乗的抗酸化化粧料組成物。 | |
KR20050121660A (ko) | 항산화제, 피부외용제, 화장료 및 식료품 | |
WO2018146066A1 (fr) | Extraits de la liane marsdenia cundurango, compositions cosmetiques les comprenant et leurs utilisations cosmétiques | |
JP2008303147A (ja) | 皮膚外用剤 | |
JPH06336422A (ja) | 皮膚外用剤 | |
JP2009185007A (ja) | ケラチノサイト成長因子産生促進剤 | |
JP5144362B2 (ja) | 皮膚外用剤 | |
JP2006199611A (ja) | 化粧料 | |
JP2001199867A (ja) | メラノサイトのデンドライトの伸長抑制剤及びそれを含有する化粧料 | |
JP6415870B2 (ja) | 皮膚外用剤 | |
JP2000327549A (ja) | カムカムエキスを含む化粧料 | |
JP2011046646A (ja) | 抗酸化剤及び皮膚外用剤 | |
JP2006282536A (ja) | スーパーオキサイド消去剤、ラジカル消去剤、過酸化水素消去剤および皮膚外用剤 | |
JP2008074730A (ja) | 保湿剤、抗老化剤、美白剤、抗炎症剤、及び抗酸化剤 | |
JP2011148742A (ja) | 細胞賦活剤及び皮膚外用剤 | |
JP4994684B2 (ja) | 保湿剤、細胞賦活剤、及び抗酸化剤 | |
JP2018070524A (ja) | 表皮細胞賦活剤 | |
JP6805514B2 (ja) | 脱脂米ぬか抽出物を含有する組成物 | |
JP3734222B2 (ja) | 皮膚外用剤、細胞賦活剤、及び抗酸化剤 | |
JP2013079208A (ja) | プロヒビチン産生促進剤 | |
JP4936754B2 (ja) | 保湿剤、細胞賦活剤、及びコラゲナーゼ阻害剤 | |
JP4916150B2 (ja) | 保湿剤、細胞賦活剤、抗酸化剤、及び皮膚外用剤、 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20170519 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20180220 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180306 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180501 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20180925 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20181015 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6420969 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |